Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Atossa Genetics Inc diskutieren

Atossa Genetics Inc

WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Aktie / Ausrüstung & Versorgung / Micro Cap /

1,46 €
2,38 %

Atossa Therapeutics, Inc. (NASDAQ: ATOS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ATOS provided by MarketBeat

Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for ATOS provided by MarketBeat

Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for ATOS provided by MarketBeat

Einschätzung Buy
Rendite (%) 55,82 %
Kursziel 3,71
Veränderung
Endet am 12.02.25

Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock.
Ratings data for ATOS provided by MarketBeat

Einschätzung Buy
Rendite (%) -21,17 %
Kursziel 3,72
Veränderung
Endet am 02.04.25

Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for ATOS provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,70 %
Kursziel 3,76
Veränderung
Endet am 16.04.25

Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ratings data for ATOS provided by MarketBeat